AllianceBernstein’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-47,800
| Closed | -$76.5K | – | 3248 |
|
|
2025
Q1 | $76.5K | Hold |
47,800
| – | – | ﹤0.01% | 3092 |
|
|
2024
Q4 | $172K | Hold |
47,800
| – | – | ﹤0.01% | 3051 |
|
|
2024
Q3 | $272K | Buy |
47,800
+2,020
| +4% | +$11.5K | ﹤0.01% | 2955 |
|
|
2024
Q2 | $212K | Buy |
+45,780
| New | +$212K | ﹤0.01% | 3014 |
|
|
2023
Q2 | – | Sell |
-52,000
| Closed | -$163K | – | 3181 |
|
|
2023
Q1 | $163K | Hold |
52,000
| – | – | ﹤0.01% | 2956 |
|
|
2022
Q4 | $307K | Buy |
52,000
+4,300
| +9% | +$25.4K | ﹤0.01% | 2860 |
|
|
2022
Q3 | $418K | Sell |
47,700
-3,100
| -6% | -$27.2K | ﹤0.01% | 2723 |
|
|
2022
Q2 | $383K | Sell |
50,800
-93,921
| -65% | -$708K | ﹤0.01% | 2790 |
|
|
2022
Q1 | $3.51M | Buy |
144,721
+42,154
| +41% | +$1.02M | ﹤0.01% | 1750 |
|
|
2021
Q4 | $3.3M | Buy |
102,567
+21,370
| +26% | +$688K | ﹤0.01% | 1834 |
|
|
2021
Q3 | $3.63M | Buy |
81,197
+19,915
| +32% | +$890K | ﹤0.01% | 1772 |
|
|
2021
Q2 | $2.32M | Buy |
+61,282
| New | +$2.32M | ﹤0.01% | 2099 |
|